Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
66 studies found for:    "Pilocytic astrocytoma"
Show Display Options
Rank Status Study
21 Completed Study of Blood and Cheek Cell Samples From Patients With Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review
22 Completed Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma
Conditions: Brain and Central Nervous System Tumors;   Infection
Interventions: Other: laboratory biomarker analysis;   Other: questionnaire administration
23 Completed Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
Condition: Central Nervous System Lymphoma
Interventions: Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
24 Completed Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: therapeutic autologous lymphocytes;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis
25 Active, not recruiting Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: everolimus;   Drug: temozolomide;   Radiation: radiation
26 Completed Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib;   Drug: temozolomide;   Other: pharmacological study
27 Completed Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: tamoxifen citrate;   Drug: topotecan hydrochloride;   Other: pharmacological study
28 Completed
Has Results
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Condition: Cancer
Interventions: Drug: Fentanyl sublingual spray;   Drug: Placebo
29 Completed Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: Erlotinib + Sirolimus
30 Completed Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Chemotherapeutic Agent Toxicity;   Infertility
Intervention:
31 Completed Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers
Condition: Stage IV Melanoma
Interventions: Biological: recombinant interferon alfa-2b;   Drug: cisplatin;   Drug: sodium stibogluconate;   Drug: dacarbazine;   Drug: vinblastine
32 Completed
Has Results
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique
33 Recruiting Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Metastatic Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Small Intestine Cancer
Interventions: Genetic: DNA analysis;   Other: immunologic technique;   Other: pharmacological study;   Radiation: iodine I 131 monoclonal antibody 3F8;   Radiation: 131I-3F8
34 Completed Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: imatinib mesylate;   Other: pharmacological study;   Procedure: conventional surgery
35 Completed Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Cognitive/Functional Effects;   Fatigue;   Metastatic Cancer;   Psychosocial Effects of Cancer and Its Treatment;   Radiation Toxicity
Interventions: Drug: donepezil hydrochloride;   Other: placebo
36 Completed Temozolomide in Treating Patients With Low-Grade Glioma
Condition: CNS Tumor, Adult
Intervention: Drug: temozolomide
37 Completed Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: chemotherapy;   Procedure: conventional surgery;   Procedure: magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging;   Radiation: radiation therapy
38 Completed Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer;   Radiation Toxicity
Intervention: Other: Questionnaire
39 Active, not recruiting Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lonafarnib;   Drug: temozolomide
40 Completed BCX-1777 in Treating Patients With Refractory Cancer
Condition: Cancer
Intervention: Drug: forodesine hydrochloride

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years